A patent review on efficient strategies for the total synthesis of pazopanib, regorafenib and lenvatinib as novel anti-angiogenesis receptor tyrosine kinase inhibitors for cancer therapy
Pezhman Shiri, Sorour Ramezanpour, Ali Mohammad Amani, Wim Dehaen
Topics & Concepts
RegorafenibPazopanibLenvatinibAngiogenesisTyrosine kinaseCancer researchMedicinePharmacologyReceptor tyrosine kinaseSorafenibKinaseCancerSunitinibInternal medicineChemistryReceptorColorectal cancerBiochemistryHepatocellular carcinomaChemical Reactions and IsotopesScience, Research, and MedicineAdvanced Breast Cancer Therapies